Zivo Bioscience, Inc. (ZIVO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2024-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$8.65M

Year ended 2021-12-31

2012-12-31 EBITDA (USD) 2021-12-31

Period ended	EBITDA	Change YoY	Source filing
2021-12-31	-$8.65M	n/c	2023-03-14, From 2021-01-01
2020-12-31	-$8.56M	n/m	2022-04-22, From 2020-01-01
2019-12-31	-$8.35M	n/m	2021-02-25, From 2019-01-01
2018-12-31	-$6.13M	n/m	2020-03-26, From 2018-01-01
2017-12-31	-$6.31M	n/m	2019-02-12, From 2017-01-01
2016-12-31	-$3.47M	n/a	2018-02-21, From 2016-01-01
No annual figure between 2014-12-31 and 2016-12-31.
2014-12-31	-$5.13M	n/m	2016-03-29, From 2014-01-02
2013-12-31	-$3.09M	n/m	2015-04-06, From 2013-01-02
2012-12-31	-$2.01M	n/a	2014-03-31, From 2012-01-02